OnCore BioPharma Inc. Email Format

BiotechnologyPennsylvania, United States2-10 Employees

OnCore BioPharma Inc. is a biotechnology research company based in Doylestown, Pennsylvania. It originated from a 2015 merger with Tekmira Pharmaceuticals Corp.; after the transaction, Tekmira adopted the Arbutus Biopharma Corporation name. As the merged entity, it concentrates on developing therapies aimed at curing chronic hepatitis B virus infection. The organization operates with a small staff and conducts its research within the biotechnology sector.

Positioned in the biotechnology research industry, Arbutus focuses on advancing treatments for chronic HBV. In 2025, it established a Scientific Advisory Board comprising leaders in the field to guide its programs. In March 2026, the company announced a partnership with Moderna Therapeutics, indicating ongoing collaboration in its work.

Sign up for free to view info

Company overview Employee directory